X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2088) 2088
Book Review (341) 341
Publication (142) 142
Book Chapter (6) 6
Conference Proceeding (3) 3
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1820) 1820
ursodeoxycholic acid (1215) 1215
humans (1111) 1111
animals (943) 943
male (846) 846
ursodeoxycholic acid - pharmacology (823) 823
pharmacology & pharmacy (577) 577
rats (504) 504
gastroenterology & hepatology (485) 485
female (478) 478
ursodeoxycholic acid - therapeutic use (359) 359
primary biliary-cirrhosis (322) 322
liver (284) 284
adult (275) 275
bile acids (262) 262
middle aged (261) 261
liver - metabolism (251) 251
cholestasis (245) 245
mice (242) 242
bile acids and salts - metabolism (232) 232
liver - drug effects (223) 223
apoptosis (222) 222
bile-acids (210) 210
cholagogues and choleretics - pharmacology (210) 210
bile (203) 203
ursodiol (202) 202
bile acids and salts - pharmacology (196) 196
biochemistry & molecular biology (185) 185
chenodeoxycholic acid (179) 179
apoptosis - drug effects (178) 178
chenodeoxycholic acid - pharmacology (172) 172
abridged index medicus (171) 171
aged (162) 162
deoxycholic acid (157) 157
rats, sprague-dawley (157) 157
rats, wistar (152) 152
cholagogues and choleretics - therapeutic use (142) 142
taurochenodeoxycholic acid - pharmacology (140) 140
ursodeoxycholic acid - administration & dosage (139) 139
dose-response relationship, drug (135) 135
cells, cultured (134) 134
deoxycholic acid - analogs & derivatives (134) 134
bile - metabolism (125) 125
expression (125) 125
oxidative stress (125) 125
cholesterol (123) 123
acids (120) 120
metabolism (120) 120
liver - pathology (118) 118
medicine, research & experimental (117) 117
primary sclerosing cholangitis (116) 116
ursodeoxycholic acid - analogs & derivatives (114) 114
analysis (113) 113
liver diseases (112) 112
time factors (112) 112
liver cirrhosis, biliary - drug therapy (111) 111
disease models, animal (104) 104
activation (103) 103
disease (100) 100
oncology (98) 98
rodents (97) 97
tauroursodeoxycholic acid (96) 96
ursodeoxycholic acid - metabolism (96) 96
kinetics (95) 95
bile acid (90) 90
cholesterol - metabolism (90) 90
hepatocytes (89) 89
hepatocytes - drug effects (87) 87
physiological aspects (86) 86
liver-disease (85) 85
treatment outcome (85) 85
gastroenterology and hepatology (83) 83
research (81) 81
bile - drug effects (80) 80
pregnancy (80) 80
cirrhosis (79) 79
cells (78) 78
bile acids and salts - blood (77) 77
inflammation (77) 77
bile acids and salts - chemistry (76) 76
care and treatment (75) 75
chemistry, medicinal (75) 75
double-blind (75) 75
rat hepatocytes (75) 75
mice, inbred c57bl (74) 74
deoxycholic acid - pharmacology (73) 73
gene expression (73) 73
hepatocytes - metabolism (73) 73
in-vitro (72) 72
mechanisms (72) 72
health aspects (71) 71
induced apoptosis (71) 71
physiology (71) 71
primary biliary cirrhosis (71) 71
cancer (70) 70
cell survival - drug effects (70) 70
in vitro techniques (70) 70
rat (70) 70
cell line, tumor (69) 69
ursodeoxycholic acid - chemistry (69) 69
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2006) 2006
Japanese (29) 29
Chinese (12) 12
French (11) 11
German (11) 11
Russian (9) 9
Spanish (7) 7
Polish (2) 2
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Graphical abstract 
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | Gastroenterology & Hepatology | TRANSPORT | Endokrinologi och diabetes | FEEDBACK-REGULATION | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | EXPRESSION | Endocrinology and Diabetes | ADIPOSE-TISSUE
Journal Article
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 06/2017, Volume 312, Issue 6, pp. G550 - G558
Inflammatory bowel diseases (IBD) comprise a group of common and debilitating chronic intestinal disorders for which currently available therapies are often... 
Inflammatory bowel disease | Epithelium | Barrier function | Bile acid | Cytokine | cytokine | APOPTOSIS | ACTIVATION | PHYSIOLOGY | bile acid | ULCERATIVE-COLITIS | HEALTHY | inflammatory bowel disease | MODELS | INFLAMMATION | epithelium | INTESTINAL BARRIER | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | barrier function | BILE-ACIDS | WATER | Dextran Sulfate | Intestinal Mucosa - metabolism | Ursodeoxycholic Acid - analogs & derivatives | Humans | Colon - drug effects | Male | Intestinal Mucosa - drug effects | Dose-Response Relationship, Drug | Lithocholic Acid - pharmacology | Time Factors | Biotransformation | Colitis - chemically induced | Inflammation Mediators - metabolism | Disease Models, Animal | Bacteria - metabolism | Cytokines - metabolism | Anti-Inflammatory Agents - pharmacology | Colon - pathology | Mice, Inbred C57BL | Gastrointestinal Microbiome | Intestinal Mucosa - microbiology | Colon - metabolism | HT29 Cells | Ursodeoxycholic Acid - pharmacology | Animals | Colitis - microbiology | Colitis - metabolism | Colon - microbiology | Ursodeoxycholic Acid - metabolism | Colitis - prevention & control | Intestinal Mucosa - pathology | Dextran | Metabolites | Anti-inflammatory drugs | Analysis | Gastrointestinal diseases | Ursodiol | Inflammation | Sulfates | Mass spectrometry | Deoxycholic acid | Physiological aspects | Colon (Anatomy) | Inflammatory bowel diseases | Bile acids | Epithelial cells | Mucosa | Mass spectroscopy | Tumor necrosis factor-α | Chromatography | Ursodeoxycholic acid | Interleukin 6 | Gas chromatography | Acids | Sodium | Intestine | Rodents | Sodium sulfate | γ-Interferon | Interferon | Colon | Sulfate | Bile | Index Medicus
Journal Article
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 02/2013, Volume 304, Issue 3, pp. 227 - 234
Journal Article
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 01/2011, Volume 108, Issue 4, pp. 1403 - 1408
This study describes a unique function of taurocholate in bile canalicular formation involving signaling through a cAMP-Epac-MEK-Rap1-LKB1-AMPK pathway. In rat... 
P-glycoprotein | Primary hepatocytes | Occludin | ACTIVATED PROTEIN-KINASE | RAT HEPATOCYTES | primary hepatocytes | SANDWICH CONFIGURATION | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | LKB1 | SIGNAL-TRANSDUCTION | MAINTENANCE | occludin | IN-VITRO | EPITHELIAL-CELLS | CAMP PRODUCTION | Cholagogues and Choleretics - pharmacology | Mitogen-Activated Protein Kinase Kinases - genetics | Bile Acids and Salts - pharmacology | Green Fluorescent Proteins - genetics | Hepatocytes - metabolism | Dose-Response Relationship, Drug | Mitogen-Activated Protein Kinase Kinases - metabolism | Hepatocytes - cytology | Guanine Nucleotide Exchange Factors - metabolism | Adenylate Kinase - metabolism | Chenodeoxycholic Acid - pharmacology | Cell Polarity - drug effects | Cyclic AMP - metabolism | Hepatocytes - drug effects | Protein-Serine-Threonine Kinases - metabolism | Taurocholic Acid - pharmacology | Green Fluorescent Proteins - metabolism | rap1 GTP-Binding Proteins - metabolism | Guanine Nucleotide Exchange Factors - genetics | Cells, Cultured | Protein-Serine-Threonine Kinases - genetics | Rats | Imines - pharmacology | Rats, Sprague-Dawley | Blotting, Western | Microscopy, Confocal | Ursodeoxycholic Acid - pharmacology | Animals | Signal Transduction - drug effects | Models, Biological | Adenylate Kinase - antagonists & inhibitors | Adenylate Kinase - genetics | rap1 GTP-Binding Proteins - genetics | Measurement | Bile acids | Physiological aspects | Polarity (Biology) | Glycoproteins | Properties | Health aspects | Liver cells | Studies | Enzymes | Cell culture | Molecular structure | Rodents | Cells | Index Medicus | Biological Sciences
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 08/2017, Volume 232, Issue 8, pp. 2231 - 2245
Journal Article
FASEB Journal, ISSN 0892-6638, 09/2017, Volume 31, Issue 9, pp. 3848 - 3857
Journal Article